These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12004443

  • 1. [Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].
    Einecke U.
    MMW Fortschr Med; 2002 Apr 11; 144(15):14. PubMed ID: 12004443
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED, Preddie DC.
    Ethn Dis; 2002 Apr 11; 12(4):S3-49-52. PubMed ID: 12477155
    [Abstract] [Full Text] [Related]

  • 3. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?
    Lewis EJ, Lewis JB.
    J Am Soc Nephrol; 2004 May 11; 15(5):1358-60. PubMed ID: 15100380
    [No Abstract] [Full Text] [Related]

  • 4. Diabetic nephropathy.
    Goto A.
    N Engl J Med; 2002 Sep 19; 347(12):947-8; author reply 947-8. PubMed ID: 12239270
    [No Abstract] [Full Text] [Related]

  • 5. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
    Kota SK, Meher LK, Jammula S, Kota SK, Modi KD.
    Diabetes Metab Syndr; 2012 Sep 19; 6(4):215-7. PubMed ID: 23199543
    [Abstract] [Full Text] [Related]

  • 6. Treating diabetic nephropathy--are there only economic issues?
    Mitch WE.
    N Engl J Med; 2004 Nov 04; 351(19):1934-6. PubMed ID: 15516698
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of diabetic nephropathy].
    Barna I.
    Orv Hetil; 2003 Jan 26; 144(4):165-72. PubMed ID: 12621814
    [Abstract] [Full Text] [Related]

  • 8. Diabetes and ACE inhibitors.
    Boulton AJ, Gokal R.
    J Hum Hypertens; 1990 Oct 26; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights].
    Martinelli L, Ceriello A.
    Recenti Prog Med; 2003 Mar 26; 94(3):131-5. PubMed ID: 12677781
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
    Rosner MH, Okusa MD.
    Arch Intern Med; 2003 May 12; 163(9):1025-9. PubMed ID: 12742799
    [Abstract] [Full Text] [Related]

  • 11. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 12; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 12. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
    Zidek W.
    MMW Fortschr Med; 2004 Oct 14; 146(42):51-2. PubMed ID: 15536706
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 14; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Blankfield RP.
    N Engl J Med; 2002 Feb 28; 346(9):705-7. PubMed ID: 11870250
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S.
    Dan Med Bull; 2004 Aug 28; 51(3):274-94. PubMed ID: 16009059
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB, Britton ML.
    Pharmacotherapy; 2005 Nov 28; 25(11):1602-20. PubMed ID: 16232022
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B.
    Curr Med Res Opin; 2004 Mar 28; 20(3):333-40. PubMed ID: 15025842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.